Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT03809702
Eligibility Criteria:
Inclusion Criteria:
* Patients of HZ presenting within 72 hours of onset of rash,
* With pain score 40 or above on 100 mm pain Visual Analogue Scale at the screening visit,
* Giving written consent for the study.
* Age between 18-70 years
Exclusion Criteria:
* HZ presenting after 72 hours of onset
* Pain score less than 40 at baseline
* Who took the stable doses of oral analgesics like: NSAIDs, acetaminophen, opioids and antidepressant within six hours of screening visit
* Using Pregabalin and Gabapentin within last 72 hours
* Nerve block therapy within the last 48 hours
* History of hypersensitivity to the drug or its ingredients
* Use of topical medications within 12 hours
* Unable to come for follow up because of severe systemic illness
* Significant hepatic and renal disease,
* Bed ridden patients or those who are physically unfit for follow up visits.
* Ethically considered vulnerable members- pregnant/lactating mothers/newborn/children below 12 years /physically or mentally challenged individuals/HIV/ AIDS/IV drug users
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03809702
Study Brief:
Protocol Section:
NCT03809702